|
|
| | agathisflavone Basic information |
| Product Name: | agathisflavone | | Synonyms: | agathisflavone;4',4''',5,5'',7,7''-Hexahydroxy-6,8''-biflavone;5,5',7,7'-Tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-6,8'-bi[4H-1-benzopyran]-4,4'-dione;6,8''-Bi[4',5,7-trihydroxyflavone];8'-Biapigenin;6,8'-Biapigenin;[6,8'-Bi-4H-1-benzopyran]-4,4'-dione, 5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)- | | CAS: | 28441-98-7 | | MF: | C30H18O10 | | MW: | 538.46 | | EINECS: | | | Product Categories: | | | Mol File: | 28441-98-7.mol |  |
| | agathisflavone Chemical Properties |
| Boiling point | 929.1±65.0 °C(Predicted) | | density | 1.656±0.06 g/cm3(Predicted) | | pka | 5.41±0.40(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | agathisflavone Usage And Synthesis |
| Uses | Agathisflavone is a flavonoid with antioxidant, anti-inflammatory, antiviral, antiparasitic, cytotoxic, neuroprotective, and hepatoprotective activities. Agathisflavone can improve tissue repair in a spinal cord injury model in rats[1][2][3]. | | Definition | ChEBI: A biflavonoid that is obtained by oxidative coupling of two molecules of apigenin resulting in a bond between positions C-6 and C-8 of the two chromene rings. | | References | [1] Islam MT, et, al. Agathisflavone: Botanical sources, therapeutic promises, and molecular docking study. IUBMB Life. 2019 Sep;71(9):1192-1200. DOI:10.1002/iub.2053
[2] Freitas CS, et, al. Agathisflavone, a Biflavonoid from Anacardium occidentale L., Inhibits Influenza Virus Neuraminidase. Curr Top Med Chem. 2020;20(2):111-120. DOI:10.2174/1568026620666191219150738
[3] Nascimento RP, et, al. Agathisflavone as a Single Therapy or in Association With Mesenchymal Stem Cells Improves Tissue Repair in a Spinal Cord Injury Model in Rats. Front Pharmacol. 2022 Apr 5;13:858190. DOI:10.3389/fphar.2022.858190 |
| | agathisflavone Preparation Products And Raw materials |
|